![Mary Joan Hampson-Carlin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mary Joan Hampson-Carlin
Corporate Officer/Principal en Laureate Biopharmaceutical Services, Inc. .
Perfil
Mary Joan Hampson-Carlin is currently the Vice President-Quality Systems at Laureate Biopharmaceutical Services, Inc. She completed her undergraduate degree at Quinnipiac University and her MBA at the University of New Haven.
Cargos activos de Mary Joan Hampson-Carlin
Empresas | Cargo | Inicio |
---|---|---|
Laureate Biopharmaceutical Services, Inc.
![]() Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 31/07/2009 |
Formación de Mary Joan Hampson-Carlin.
Quinnipiac University | Undergraduate Degree |
University of New Haven | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Laureate Biopharmaceutical Services, Inc.
![]() Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Mary Joan Hampson-Carlin